Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Side effect concerns and their impact on women’s uptake of modern family planning methods in rural Ghana: a mixed methods study

BMC Women's Health volume 20, Article number: 57 (2020) Cite this article

Abstract

Background

Despite availability of modern contraceptive methods and documented unmet need for family planning in Ghana, many women still report forgoing modern contraceptive use due to anticipated side effects. The goal of this study was to examine the use of modern family planning, in particular hormonal methods, in one district in rural Ghana, and to understand the role that side effects play in women’s decisions to start or continue use.

Methods

This exploratory mixed-methods study included 281 surveys and 33 in-depth interviews of women 18–49 years old in the Amansie West District of Ghana between May and July 2018. The survey assessed contraceptive use and potential predictors of use. In-depth interviews examined the context around uptake and continuation of contraceptive use, with a particular focus on the role of perceived and experienced side effects.

Results

The prevalence of unmet need for modern family planning among sexually active women who wanted to avoid pregnancy (n = 135) was 68.9%. No factors were found to be significantly different in comparing those with a met need and unmet for modern family planning. Qualitative interviews revealed significant concerns about side effects stemming from previous method experiences and/or rumors regarding short-term impacts and perceived long-term consequences of family planning use. Side effects mentioned include menstrual changes (heavier bleeding, amenorrhea or oligomenorrhea), infertility and childbirth complications.

Conclusion

As programs have improved women’s ability to access modern family planning, it is paramount to address patient-level barriers to uptake, in particular information about side effects and misconceptions about long-term use. Unintended pregnancies can be reduced through comprehensive counseling about contraceptive options including accurate information about side effects, and the development of new contraceptive technologies that meet women’s needs in low-income countries.

Peer Review reports

Background

Modern family planning methods are a cost-effective strategy for reducing high-risk pregnancies, decreasing unsafe abortions, and allowing for birth spacing and limiting [1,2,3,4]. Despite advances in contraceptive technology and availability, 214 million women had an unmet need for modern family planning in 2017 [5].

In order to inform the delivery of family planning services, it is important to understand the factors and characteristics that contribute to a woman’s decision to use modern family planning. Demographic factors influencing family planning use may include age, family size, distance from a health care facility and education level [6, 7]. Additionally, family planning use is influenced by women’s norms and perceptions. Women may face cultural or religious pressures against using family planning, often rooted in beliefs that family planning leads to unfaithfulness or interferes with goals of procreation [7, 8].

Side effects of modern family planning methods, either experienced or anticipated, have been identified as a common reason that women either choose not to start or discontinue contraceptives. Side effects include menstrual changes (heavier bleeding, amenorrhea or oligomenorrhea), changes in weight, headaches, dizziness, nausea, and cardiovascular impacts. In addition, women may harbor fears of long-term effects of contraceptive use, such as infertility and childbirth complications [8, 9]. A 2014 systematic review found a significant proportion of women attributed their unmet need for family planning to a fear of side effects: 28% in Africa, 23% in Asia, and 35% in Latin America and the Caribbean [10]. A fear of side effects may occur when a woman or someone she knows has experienced side effects with a method, or when rumors or overestimations or rare complications are considered factual [7, 8, 11,12,13].

Ghana has historically had one of the highest rates of unmet need for family planning in Africa, despite having a relatively strong family planning program. Ghana’s rate of unmet need among married women is 32.9 whereas many surrounding countries have a lower rate of unmet need among married women including Senegal (26.2), Nigeria (23.7) and Cote d’Ivoire (30.9) [14]. Family planning methods are available at both private and public healthcare facilities and offer a diverse contraceptive mix, including injectables, implants and hormonal birth control pills [8]. The Amansie West district has 22 public health facilities, comprised of 6 health centers and 16 Community-based Health Planning and Services compounds, 5 private health facilities and 1 hospital. Within these various health facilities modern family planning methods (pills, intrauterine devices (IUDs), and implants) can be administered by trained medical doctors, midwives, and trained Community Health Officers. Nurses in health facilities are able to administer pills and condoms. Outside of health facilities condoms, pills, and injectables are available at pharmacies and drug shops [15, 16].

Despite efforts to make contraceptives accessible, about one-third of married women have an unmet need for family planning [17]. Although the use of modern family planning methods has increased from 5 to 22% between 1988 and 2014, one in four contraceptive users discontinued use within the first year. The main reason reported for discontinuing injectables and implants were side effects or other health concerns and health concerns as a reason for non-use of modern methods in Ghana has been growing over time [12, 17].

This study was conducted with the goal of understanding modern family planning use in a rural setting of Ghana with three aims. First, we aimed to estimate the prevalence of modern family planning use and the prevalence of unmet need for modern family planning. Second, we identified factors associated with unmet need for modern family planning use, including factors at an individual, household and health care level. Lastly, we sought to qualitatively examine and understand women’s experiences with choices and behaviors related to family planning use, with a focus on the role of side effects. This data can help inform the delivery of modern contraceptives to all women wanting to delay or limit their pregnancies.

Methods

Setting

This exploratory mixed-methods study was conducted in the Amansie West District, in the Ashanti Region of Ghana. The population of the area is almost entirely rural (95.6%), with an estimated population of 149,437 in 2014 and annual growth of 2.7% [18, 19].

Sampling

The study included 281 household surveys and 33 in-depth interviews of women 18–49 years old from six subdistricts of the Amansie West District. Data were gathered from May to July 2018 as part of a larger study examining the role of community health workers (CHWs) in family planning use. Six of the seven subdistricts within the Amansie West District were selected based on accessibility and penetration of the national CHW program. The six sub-districts were divided into 11 geographical zones containing at least 100 women of reproductive age (18–49) whose household was registered by a CHW. An average of 30 women were recruited from each zone in order to have geographic representation in our sample; the final sample size was informed by the resources available to us in this study. A subset of individuals who completed the household survey were purposively sampled to participate in a separate in-depth interview. Participants for the in-depth interview were selected based on current, past or lack of modern method use.

Procedures

To collect the survey data, a team of six female research assistants, bilingual in English and Twi, were trained in ethics and research procedures. The research assistants approached women in their homes to tell them about the study and invite them to participate. After written informed consent, the research assistant administered the structured interview using an electronic tablet, which took approximately 45 min. At the end of the interview, participants were asked if they might be interested in taking part in a subsequent in-depth interview; if yes, then their contact information was collected to schedule the interview at a later time.

To conduct in-depth interviews (IDIs), three bilingual nurses from the district were trained on research ethics and qualitative research. IDIs were scheduled in participants’ homes at a time that was convenient and maximized privacy. Participants were provided a separate written informed consent for the IDI, which included consent for audio recording. IDIs were conducted in Twi and lasted on average 30 min. Following each interview, field notes were written and then later reviewed with the full research team.

Instruments

Structured survey

The structured survey was created based on a review of the literature and consultation with local public health professionals. The survey was locally translated into Twi and reviewed by multiple individuals to confirm accurate translation. The survey was pre-tested in a rural community prior to data collection, which resulted in slight modifications.

The survey included the following constructs: demographics; pregnancy history; knowledge and perceived availability of various forms of contraceptives; use of contraceptives; pregnancy intention and attitudes towards pregnancy (α = 0.81); depression PHQ-9 (α = 0.74); autonomy (α = 0.77); partner communication (α = 0.74); freedom from coercion (α = 0.80); and partner support (α = 0.80) [20,21,22,23,24].

In-depth interviews

The in-depth interviews were conducted using a semi-structured guide that included open-ended questions and probes to explore community and individual perspectives of family planning, barriers to use, experiences with family planning use, and reasons for using or not using family planning. The interview guide developed for this study, available as a supplementary file, was reviewed by local public health professionals and pretested in the community. Research assistants translated the guide into Twi during the interviews to adjust the phrasing for a natural, casual conversation.

Data analysis

Survey data were analyzed using R Studio. In order to define a population that could be in need of community-based contraception, we excluded individuals who were not sexually active (defined as three months since last sex), currently pregnant, wished to become pregnant in the next few months, or reported being infertile (includes hysterectomy) from the analysis. This resulted in a sample for analysis of 135 women. While definitions of unmet need for population level analyses typically include women, who have unwanted/mistimed pregnancies the parent study was particularly interested in community level modern family planning method gaps that might be facilitated by community health workers. We were also most interested in highly effective modern methods and thus current use of natural and barrier methods were also excluded from our main analyses. Individuals were classified as having an unmet need for modern contraception if they met the criteria for inclusion but reported that they were not using a hormonal method (pills, injectables, implants), female sterilization, male sterilization or an IUD. After examining descriptive statistics, bivariate analysis explored whether key factors were significantly associated with unmet need for these highly effective modern family planning methods. Because bivariate statistics were not significant, multivariate statistics were not used.

Qualitative analysis was conducted using applied thematic analysis [25]. Audio recordings were simultaneously translated and transcribed in English. NVivo 12 was used to facilitate the organization and coding of transcripts. Emergent themes were identified through an iterative process of summary memos and open coding, which led to the development of a structured codebook. Overarching domains were created as parent codes, and child codes were used to organize emerging themes. Coded texts were reviewed and synthesized, and representative quotes were identified to capture meaning and provide context.

Results

Demographics

Table 1 summarizes the demographics of the sub-sample of participants who had a current need for modern family planning (n = 135). On average, participants were 29.4 years of age. About half (45%, n = 61) were married. In this community couples who have undergone customary marital rights or those that are living together with children were considered to be married. Half of the participants (52%, n = 70) had three or more children. Education was low, with only 15.6% of participants reporting any secondary school education.

Table 1 Sample demographics and characteristics (n = 135)
Full size table

Family planning use

Considering the family planning needs of the sample, 31.1% (n = 42) had a met need, and 68.9% (n = 93) had an unmet need. More than half (n = 23) of women with a met need were using the injectable, Depo-Medroxyprogesterone (DMPA) (Table 2). In the bivariate analysis of factors potentially associated with family planning use (i.e., pregnancy intentions and attitudes, depression, level of autonomy, communication with their partner, freedom from coercion and levels of partner support), none of the measures were significantly associated (Table 3).

Table 2 Modern contraceptive use (n = 135)
Full size table
Table 3 Predictors of unmet need for modern family planning (n = 135)
Full size table

Qualitative insights on family planning use

In the qualitative data, two prominent themes emerged to explain unmet need: concerns about side effects and misconceptions about the long-term effects of family planning (Table 4).

Table 4 Barriers to uptake and continuation of modern family planning methods
Full size table

Side effects

Side effects were mentioned as a potential concern in all qualitative interviews. For many, the concerns about side effects outweighed the perceived benefits of using family planning. Of the 17 participants who had discontinued family planning use, only 5 reported experiencing side effects themselves, while the majority recited side effects they believed were associated with modern family planning use. The most common concern about hormonal contraceptives was the resultant changes in menstrual patterns. There was a belief that menstruation was a means of cleansing the body, and concerns that a lack of menstruation could lead to sickness, dizziness, bloating, and fainting. Additionally, amenorrhea was concerning for women because they could no longer monitor whether or not they were pregnant.

In addition to changes in menstruation, participants mentioned other side effects they were concerned about, including sickness, dizziness, and changes in weight. Reduction in weight was seen as an undesirable side effect, while weight gain was seen as a desirable side effect. The seven participants currently using DMPA had experienced at least one of these side effects. Even in cases where participants reported support from their partner, family or religious community to use family planning, anxiety about side effects deterred them from using family planning—support was not enough to overcome what the women articulated as unacceptable side effects. Women who had not experienced side effects themselves discussed side effects as the most common reason that other women did not use modern family planning.

Misconceptions about long-term impacts

Participants both using and not using a modern contraceptive method reported misconceptions in the community, particularly about hormonal methods. The most common misconceptions were rumors about the long-term adverse effects caused by modern family planning. Women recited rumors that family planning use led to fibroids, infertility, birth complications, and even premature death. In most cases, these long-term impacts were attributed to changes in menstrual patterns, typically associated with injectables and implants.

Three participants discussed rumors that implants caused fainting and death due to a restriction in blood flow. The rumors and misconceptions that were reported about family planning use spanned all 14 communities that were included in the qualitative portion of the study, illustrating the ubiquitous nature of these concerns.

Discussion

Knowledge of modern family planning methods is high throughout Ghana; nationwide, 99% of women with an unmet need for family planning identified at least one modern method [17]. Despite high levels of knowledge, we found that among 135 women who were sexually active and wanting to avoid pregnancy, a majority (68.9%) had an unmet need for a highly effective modern family planning method. When examining factors that might explain unmet need, no significant associations were identified. Our qualitative data suggests that fear of side effects and misconceptions about family planning methods is likely driving the gap between knowledge and behavior in family planning use. This study suggests a need to address accurate information about family planning methods, especially injectables the most common form of modern family planning in African countries [26]. Addressing structural barriers of access to contraceptives will be insufficient if misinformation about side effects and long-term adverse effects persist.

In order to meet the needs of women who wish to postpone or limit their pregnancies, it is important to have targeted interventions to address the fears and concerns caused by menstrual bleeding changes that frequently occur with hormonal methods such as injectables and implants. This is especially important in low- and middle-income countries (LMICs) where the use of injectables is being prompted due to its higher effectiveness level, as compared to oral hormonal pills, and the ability to use the product discretely [27, 28]. The universal concern about menstruation in our sample demonstrates the need for improved counseling, before and during use, to educate women about the role of menstruation in reproduction and how hormones impact menstrual patterns [8, 12, 13]. Both uptake and continuation of reversible contraceptives requires regular counseling, scheduled follow-up, and clinical management of contraceptive side effects [29]. Health workers, including CHWs, involved in providing family planning education and provision should be equipped to provide reproductive education to help women understand and differentiate between nonharmful and harmful side effects. FHI360 has developed a job aid called “NORMAL” to help health workers counsel clients on expected changes of menstruation on various forms of hormonal contraception [9]. There is evidence that job aids with accurate injectable information have been shown to increase injectable use in low-resource settings and could be adapted to the Ghanaian context [30]. CHWs need additional training to help women understand and manage side effects from modern family planning. Job aids such as “NORMAL” could provide CHWs with a tool to better counsel and manage clients regarding uptake and continuation of family planning methods. Comprehensive counseling, including accurate information on side effects, has been shown to increase continuation of modern methods [31, 32]. Additional qualitative research among different communities is needed to understand the beliefs that underlie women’s concerns about menstrual changes. Better understanding these beliefs can inform culturally congruent counseling approaches to promote the uptake and sustainability of family planning methods.

Certain side effects will always be considered unacceptable for some women, making their family planning options more limited. A long-term solution for family planning coverage requires investments in new contraceptive technologies that are responsive to women’s preferences and needs. This includes the development of both hormonal and nonhormonal long-acting reversible contraceptives that are accessible and effective in low-income settings. Several new contraceptive technologies under development may hold promise, including biodegradable implants, longer-acting injectables, IUDs that are easier to insert, and non-hormonal vaginal rings [33, 34]. Hopefully, these new technologies will address some barriers to family planning use and provide more options for women and couples to limit or space their pregnancies.

The study findings must be interpreted in the context of the study’s limitations. First, social desirability biases may be present in the survey results. The in-depth interviews were conducted by local nurses responsible for administering family planning methods in the clinics; therefore, participants may have been less likely to speak negatively about services or areas in which the nurses work. It is important to note variation among these interviews, as some participants were more willing to discuss and share than others. Second, the in-depth interviews were simultaneously translated and transcribed from the local language, Twi, into English; therefore, some details and phrasing may have been lost in the process. Third, the sample size for the survey was not powered to detect statistically significant differences. Lastly, we did not explore more deeply whether women felt their family planning needs were being met via barrier and/or natural methods—although less effective, some women and couples purposefully choose this option.

Conclusion

Even as modern contraceptives become increasingly accessible, women may perceive potential drawbacks of highly effective family planning methods to outweigh the benefits. The future of family planning research and implementation should focus on developing and implementing evidence-based counseling tools to promote the uptake and continuation of the current method mix and investing in the development of new family planning technologies that fit the lifestyles and needs of women in LMICs.

Availability of data and materials

The data and all related study materials may be requested from the faculty mentor on this study (Dr. Melissa Watt, melissa.watt@duke.edu).

Abbreviations

CHW:

Community Health Worker

DHS:

Demographic Health Survey

DMPA:

Depo-Medroxyprogesterone

EV/NETE:

Estradiol valerate/norethisterone enantate

IDI:

In-depth interview

IUD:

Intrauterine device

LMICs:

Low- and middle-income countries

References

  1. Ahmed S, Li Q, Liu L, Tsui AO. Maternal deaths averted by contraceptive use: An analysis of 172 countries. Lancet. 2012;380(9837):111–25. https://doi.org/10.1016/S0140-6736(12)60478-4.

    Article  PubMed  Google Scholar 

  2. Beson P, Appiah R, Adomah-Afari A. Modern contraceptive use among reproductive-aged women in Ghana: Prevalence, predictors, and policy implications. BMC Womens Health. 2018;18(1). https://doi.org/10.1186/s12905-018-0649-2.

  3. Chola L, McGee S, Tugendhaft A, Buchmann E, Hofman K. Scaling Up Family Planning to Reduce Maternal and Child Mortality: The Potential Costs and Benefits of Modern Contraceptive Use in South Africa. PLoS One. 2015;10(6):e0130077. https://doi.org/10.1371/journal.pone.0130077.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Starbird E, Norton M, Marcus R. Investing in Family Planning: Key to Achieving the Sustainable Development Goals. Global Health Sci Pract. 2016;4(2):191–210 https://doi.org/10.9745/GHSP-D-15-00374.

    Article  Google Scholar 

  5. Guttmacher Institute. ADDING IT UP: Investing in Contraception and Maternal and Newborn Health, 2017: Guttmacher Institute; 2017. https://www.guttmacher.org/fact-sheet/adding-it-up-contraception-mnh-2017 Accessed 27 Dec 2018.

  6. Ebrahim NB, Atteraya MS. Structural correlates of modern contraceptive use among Ethiopian women. Health Care Women Int. 2018;39(2):208–19. https://doi.org/10.1080/07399332.2017.1383993.

    Article  PubMed  Google Scholar 

  7. Wulifan JK, Brenner S, Jahn A, De Allegri M. A scoping review on determinants of unmet need for family planning among women of reproductive age in low and middle income countries. BMC Womens Health. 2015;16(1). https://doi.org/10.1186/s12905-015-0281-3.

  8. Staveteig S. Fear, opposition, ambivalence, and omission: Results from a follow-up study on unmet need for family planning in Ghana. PLoS One. 2017;12(7):e0182076. https://doi.org/10.1371/journal.pone.0182076.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rademacher KH, Sergison J, Glish L, Maldonado LY, Mackenzie A, Nanda G, Yacobson I. Menstrual Bleeding Changes Are NORMAL: Proposed Counseling Tool to Address Common Reasons for Non-Use and Discontinuation of Contraception. Glob Health. 2018;6(3):8.

    Google Scholar 

  10. World Health Organization. (2018, February 8). Family planning/Contraception. https://www.who.int/news-room/fact-sheets/detail/family-planning-contraception Accessed 27 Dec 2018.

  11. Casterline JB, Sathar ZA, Haque, M. ul. Obstacles to Contraceptive Use in Pakistan: A Study in Punjab. Stud Fam Plan. 2001;32(2):95–110. https://doi.org/10.1111/j.1728-4465.2001.00095.x.

    Article  CAS  Google Scholar 

  12. Machiyama K, Cleland J. Unmet Need for Family Planning in Ghana: The Shifting Contributions of Lack of Access and Attitudinal Resistance. Stud Fam Plan. 2014;45(2):203–26. https://doi.org/10.1111/j.1728-4465.2014.00385.x.

    Article  Google Scholar 

  13. Sedgh G, Hussain R. Reasons for Contraceptive Nonuse among Women Having Unmet Need for Contraception in Developing Countries. Stud Fam Plan. 2014;45(2):151–69. https://doi.org/10.1111/j.1728-4465.2014.00382.x.

    Article  Google Scholar 

  14. Family Planning 2020. (n.d.). Retrieved December 4, 2019, from https://www.familyplanning2020.org/countries.

  15. Lebetkin E, Orr T, Dzasi K, Keyes E, Shelus V, Mensah S, et al. Injectable Contraceptive Sales at Licensed Chemical Seller Shops in Ghana: Access and Reported Use in Rural and Periurban Communities. Int Perspect Sex Reprod Health. 2014;40(01):021–7. https://doi.org/10.1363/4002114.

    Article  Google Scholar 

  16. Perry R, Sharon Oteng M, Haider S, Geller S. A brief educational intervention changes knowledge and attitudes about long acting reversible contraception for adolescents in rural Ghana. J Pregnancy Reprod. 2017;1(1). https://doi.org/10.15761/JPR.1000106.

  17. The DHS Program. Demographic and Health Surveys. In: Ghana Demographic and Health Survey 2014. Rockville: GSS, GHS, and ICF International; 2015. http://dhsprogram.com/pubs/pdf/FR307/FR307.pdf. Accessed 11 Dec 2018.

    Google Scholar 

  18. Ghana Statistical Service. 2010 Population and housing census district analytical report: Amansie West. 2014. https://new-ndpc-static1.s3.amazonaws.com/CACHES/PUBLICATIONS/2016/06/06/Amansie+West+2010PHC.pdf Accessed 27 Dec 2018.

    Google Scholar 

  19. Nuamah GB, Agyei-Baffour P, Akohene KM, Boateng D, Dobin D, Addai-Donkor K. Incentives to yield to Obstetric Referrals in deprived areas of Amansie West district in the Ashanti Region, Ghana. Int J Equity Health. 2016;15(1). https://doi.org/10.1186/s12939-016-0408-7.

  20. Watt HM, Knettel AB, Choi WK, Knippler TE, May AP, Seedat S. Risk for Alcohol-Exposed Pregnancies Among Women at Drinking Venues in Cape Town, South Africa. J Stud Alcohol Drugs. 2017;78(5):795–800. https://doi.org/10.15288/jsad.2017.78.795.

    Article  PubMed  Google Scholar 

  21. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a brief depression severity measure. J General Int Med. 2001;16(9):606–13. https://doi.org/10.1046/j.1525-1497.2001.016009606.x.

    Article  CAS  Google Scholar 

  22. Rominski SD, Gupta M, Aborigo R, Adongo P, Engman C, Hodgson A, Moyer C. Female autonomy and reported abortion-seeking in Ghana, West Africa. Int J Gynecol Obstet. 2014;126(3):217–22. https://doi.org/10.1016/j.ijgo.2014.03.031.

    Article  Google Scholar 

  23. Upadhyay UD, Dworkin SL, Weitz TA, Foster DG. Development and Validation of a Reproductive Autonomy Scale. Stud Fam Plan. 2014;45(1):19–41. https://doi.org/10.1111/j.1728-4465.2014.00374.x.

    Article  Google Scholar 

  24. Norbeck JS, Lindsey AM, Carrieri VL. Further Development of the Norbeck Social Support Questionnaire: Normative Data and Validity Testing. [Editorial]. Nurs Res. 1983;32(1):4–9.

    Article  CAS  Google Scholar 

  25. Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks: SAGE Publications, Inc.; 2012. https://doi.org/10.4135/9781483384436.

    Book  Google Scholar 

  26. Bertrand JT, Sullivan TM, Knowles EA, Zeeshan MF, Shelton JD. Contraceptive Method Skew and Shifts in Method Mix in Low- and Middle-Income Countries. Int Perspect Sex Reprod Health. 2014;40(03):144–53. https://doi.org/10.1363/4014414.

    Article  PubMed  Google Scholar 

  27. Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, et al. Depo Provera. Position paper on clinical use, effectiveness and side effects. Br J Fam Plann. 1999;25(2):69–76.

    CAS  PubMed  Google Scholar 

  28. Curry L, Taylor L, Pallas SW, Cherlin E, Pérez-Escamilla R, Bradley EH. Scaling up depot medroxyprogesterone acetate (DMPA): A systematic literature review illustrating the AIDED model. Reprod Health. 2013;10:39.

    Article  CAS  Google Scholar 

  29. Ahmed K, Baeten JM, Beksinska M, Bekker L-G, Bukusi EA, Donnell D, et al. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: A randomised, multicentre, open-label trial. Lancet. 2019;0(0). https://doi.org/10.1016/S0140-6736(19)31288-7.

    Article  Google Scholar 

  30. Baumgartner JN, Morroni C, Mlobeli R, Otterness, Buga G, Chen M. Impact of a provider job aid intervention on injectable contraceptive continuation in South Africa. Stud Fam Plan. 2012;43(4):305–14. https://doi.org/10.1111/j.1728-4465.2012.00328.x.

    Article  Google Scholar 

  31. Cetina TECD, Canto P, Luna MO. Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. Contraception. 2001;63(3):143–6. https://doi.org/10.1016/S0010-7824(01)00181-0.

    Article  Google Scholar 

  32. Liu J, Shen J, Diamond-Smith N. Predictors of DMPA-SC continuation among urban Nigerian women: The influence of counseling quality and side effects. Contraception. 2018;98(5):430–7. https://doi.org/10.1016/j.contraception.2018.04.015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Brunie A, Callahan RL, Godwin CL, Bajpai J, OlaOlorun FM. User preferences for a contraceptive microarray patch in India and Nigeria: Qualitative research on what women want. PLoS One. 2019;14(6). https://doi.org/10.1371/journal.pone.0216797.

    Article  CAS  Google Scholar 

  34. Tolley EE, McKenna K, Mackenzie C, Ngabo F, Munyambanza E, Arcara J, et al. Preferences for a potential longer-acting injectable contraceptive: Perspectives from women, providers, and policy makers in Kenya and Rwanda. Glob Health Sci Pract. 2014;2(2):182–94. https://doi.org/10.9745/GHSP-D-13-00147.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors are grateful for the contributions of the data collection team and the local clinic personnel who helped to facilitate study entry. We are grateful to Bright Asare for provided assistance throughout the data collection period. At the Duke Global Health Institute, Mary Story and Randall Kramer were important advocates for the research.

Funding

This study was funded by a grant from Duke University’s Global Health Institute. Students of the funding body designed the study based on priorities identified by Ghanaian collaborators. The supplied funds were used to support data collection and management in Ghana. Analysis, interpretation, & writing were completed by the Duke students (LS and MS), in collaboration with the Ghanaian partners (NN, EA and SO), and with support from Duke faculty mentors (JB and MW).

Author information

Authors and Affiliations

  1. Duke Global Health Institute, Duke University, Box 90519, Durham, NC, 27708, USA

    Leah A. Schrumpf, Maya J. Stephens, Joy Noel Baumgartner & Melissa H. Watt

  2. Millennium Promise Ghana, 14 Bathur St, East Legon, Accra, Ghana

    Nathaniel E. Nsarko, Eric Akosah & Seth Ohemeng-Dapaah

Authors
  1. Leah A. Schrumpf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maya J. Stephens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nathaniel E. Nsarko
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric Akosah
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joy Noel Baumgartner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seth Ohemeng-Dapaah
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Melissa H. Watt
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LAS was a co-principal investigator on the study, contributed to the design of the work, analyzed and interpreted data, and was the main contributor in the writing of the manuscript. MJS was a co-principal investigator in this study, contributed to the design of the work, and analyzed and interpreted the data. NEN made substantial contributions to the conception and design of the work. EA made contributions to the design of the work and data interpretation. JNB made contributions in the interpretation of the data and has substantively revised the manuscript. SO-D made contributions to the conception and design of the work. MHW made substantial contributions to the conception and design of the work, as well as data interpretation and revisions to the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Leah A. Schrumpf.

Ethics declarations

Ethics approval and consent to participate

All study procedures and materials were approved by the Duke University Institutional Review Board (2018–0343) and Ghana Health Services Ethical Review Committee. Written consent was obtained from all participants.

Consent for publication

The informed consent form included permission to include de-identified data in publications.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schrumpf, L.A., Stephens, M.J., Nsarko, N.E. et al. Side effect concerns and their impact on women’s uptake of modern family planning methods in rural Ghana: a mixed methods study. BMC Women's Health 20, 57 (2020). https://doi.org/10.1186/s12905-020-0885-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12905-020-0885-0

Keywords

BMC Women's Health

ISSN: 1472-6874

Contact us